QU Ain, JY Chung, YH Kim - Journal of Controlled Release, 2015 - Elsevier
Gene therapy by engineered nucleases is a genetic intervention being investigated for curing the hereditary disorders by targeting selected genes with specific nucleotides for …
Tools for rapid and efficient transgenesis in" safe harbor" loci in an isogenic context remain important to exploit the possibilities of human pluripotent stem cells (hPSCs). We created …
FC Tay, JK Lim, H Zhu, LC Hin, S Wang - Advanced drug delivery reviews, 2015 - Elsevier
Widely observed dysregulation of microRNAs (miRNAs) in human cancer has led to substantial speculation regarding possible functions of these short, non-coding RNAs in …
N Tsumaki, M Okada, A Yamashita - Bone, 2015 - Elsevier
Articular cartilage covers the ends of bone and provides shock absorption and lubrication to the diarthrodial joints. Cartilage has a limited capacity for repair when injured, and there is a …
Z Xiang, Q Ye, Z Zhao, N Wang, J Li, M Zou… - Molecular Genetics and …, 2024 - Springer
Derivation of hypoimmunogenic human cells from genetically manipulated pluripotent stem cells holds great promise for future transplantation medicine and adoptive immunotherapy …
N Brookhouser, S Raman, C Potts, DA Brafman - Cells, 2017 - mdpi.com
In the decade since Yamanaka and colleagues described methods to reprogram somatic cells into a pluripotent state, human induced pluripotent stem cells (hiPSCs) have …
SY Tang, S Zha, Z Du, J Zeng, D Zhu, Y Luo… - Stem cell research & …, 2021 - Springer
Background Redirection of natural killer (NK) cells with chimeric antigen receptors (CAR) is attractive in developing off-the-shelf CAR therapeutics for cancer treatment. However, the …
CH Lau - The CRISPR journal, 2018 - liebertpub.com
CRISPR technology is rapidly evolving, and the scope of CRISPR applications is constantly expanding. CRISPR was originally employed for genome editing. Its application was then …